171 related articles for article (PubMed ID: 12940381)
1. Measles, mumps, rubella (MMR) vaccine.
Dubey AP; Banerjee S
Indian J Pediatr; 2003 Jul; 70(7):579-84. PubMed ID: 12940381
[TBL] [Abstract][Full Text] [Related]
2. Vaccines for measles, mumps, rubella, and varicella in children.
Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD004407. PubMed ID: 32309885
[TBL] [Abstract][Full Text] [Related]
3. Vaccines for measles, mumps and rubella in children.
Demicheli V; Rivetti A; Debalini MG; Di Pietrantonj C
Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD004407. PubMed ID: 22336803
[TBL] [Abstract][Full Text] [Related]
4. Vaccines for measles, mumps, rubella, and varicella in children.
Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004407. PubMed ID: 34806766
[TBL] [Abstract][Full Text] [Related]
5. Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, Illinois, June 12-13, 2000.
Halsey NA; Hyman SL;
Pediatrics; 2001 May; 107(5):E84. PubMed ID: 11331734
[TBL] [Abstract][Full Text] [Related]
6. Vaccines for measles, mumps and rubella in children.
Demicheli V; Jefferson T; Rivetti A; Price D
Cochrane Database Syst Rev; 2005 Oct; (4):CD004407. PubMed ID: 16235361
[TBL] [Abstract][Full Text] [Related]
7. The MMR Vaccine and Autism.
DeStefano F; Shimabukuro TT
Annu Rev Virol; 2019 Sep; 6(1):585-600. PubMed ID: 30986133
[TBL] [Abstract][Full Text] [Related]
8. MMR vaccine and autism: an update of the scientific evidence.
DeStefano F; Thompson WW
Expert Rev Vaccines; 2004 Feb; 3(1):19-22. PubMed ID: 14761240
[TBL] [Abstract][Full Text] [Related]
9. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial.
Sood A; Mitra M; Joshi HA; Nayak US; Siddaiah P; Babu TR; Mahapatro S; Sanmukhani J; Gupta G; Mittal R; Glueck R
Hum Vaccin Immunother; 2017 Jul; 13(7):1523-1530. PubMed ID: 28362563
[TBL] [Abstract][Full Text] [Related]
11. Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children.
Feiterna-Sperling C; Brönnimann R; Tischer A; Stettler P; Durrer P; Gaedicke G
Pediatr Infect Dis J; 2005 Dec; 24(12):1083-8. PubMed ID: 16371870
[TBL] [Abstract][Full Text] [Related]
12. Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.
Nolan T; McIntyre P; Roberton D; Descamps D
Vaccine; 2002 Dec; 21(3-4):281-9. PubMed ID: 12450703
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study.
Mrozek-Budzyn D; Kiełtyka A; Majewska R
Pediatr Infect Dis J; 2010 May; 29(5):397-400. PubMed ID: 19952979
[TBL] [Abstract][Full Text] [Related]
14. MMR vaccination and autism: is there a link?
DeStefano F; Thompson WW
Expert Opin Drug Saf; 2002 Jul; 1(2):115-20. PubMed ID: 12904145
[TBL] [Abstract][Full Text] [Related]
15. A new measles mumps rubella (MMR) vaccine: a randomized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children.
Lee CY; Tang RB; Huang FY; Tang H; Huang LM; Bock HL
Int J Infect Dis; 2002 Sep; 6(3):202-9. PubMed ID: 12718836
[TBL] [Abstract][Full Text] [Related]
16. Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines.
Schwarzer S; Reibel S; Lang AB; Struck MM; Finkel B; Gerike E; Tischer A; Gassner M; Glück R; Stück B; Cryz SJ
Vaccine; 1998; 16(2-3):298-304. PubMed ID: 9607046
[TBL] [Abstract][Full Text] [Related]
17. Measles-mumps-rubella vaccine and the development of autism.
Miller E
Semin Pediatr Infect Dis; 2003 Jul; 14(3):199-206. PubMed ID: 12913832
[TBL] [Abstract][Full Text] [Related]
18. The Immunogenicity and Safety Profile for KM-248, a Combined Measles, Mumps, and Rubella Vaccine, and Its Noninferiority to the Measles Vaccine in Healthy Japanese Children: a Phase 3 Randomized Multicenter Single-Blind Clinical Trial.
Platt H; Tochihara S; Oda Y; Ueda K
Jpn J Infect Dis; 2021 Sep; 74(5):429-436. PubMed ID: 33518626
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
Schuster V; Otto W; Maurer L; Tcherepnine P; Pfletschinger U; Kindler K; Soemantri P; Walther U; Macholdt U; Douha M; Pierson P; Willems P
Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190
[TBL] [Abstract][Full Text] [Related]
20. Is an improved measles-mumps-rubella vaccine necessary or feasible?
Atkins GJ; Cosby SL
Crit Rev Immunol; 2003; 23(4):323-38. PubMed ID: 14700273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
